IMUX
Immunic Inc
NASDAQ: IMUX · HEALTHCARE · BIOTECHNOLOGY
$10.03
-6.70% today
Updated 2026-04-29
Market cap
$135.94M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-6.20
Dividend yield
—
52W range
$5 – $15
Volume
2.8M
Immunic Inc (IMUX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-1,653.00%
ROA
-198.80%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2011 | — | $-5.88M | — | — | — |
| 2012 | — | $-6.70M | — | — | — |
| 2013 | — | $-32.72M | — | — | — |
| 2014 | — | $-47.67M | — | — | — |
| 2015 | — | $-52.02M | — | — | — |
| 2016 | $6000.00 | $-40.97M | 96.57% | -687,766.67% | -682,816.67% |
| 2017 | $0.00 | $-52.08M | — | — | — |
| 2018 | $0.00 | $-41.48M | — | — | — |
| 2019 | $0.00 | $-34.83M | — | — | — |
| 2020 | $0.00 | $-44.02M | — | — | — |
| 2021 | $0.00 | $-92.79M | — | — | — |
| 2022 | $0.00 | $-120.41M | — | — | — |
| 2023 | $0.00 | $-93.61M | — | — | — |
| 2024 | $0.00 | $-100.51M | — | — | — |
| 2025 | $0.00 | $-97.17M | — | — | — |